The multiprotein complex y-secretase proteolytically cleaves the intramembrane region of amyloid precursor protein (APP), which in turn forms the plaques found in Alzheimer's disease (AD) patients. The catalytic component of Y-secretase is the intramembrane aspartyl protease (IAP) called presenilin. Mutations in presenilin are directly linked to familial early-onset AD. Another known member of the IAP family is signal peptide peptidase (SPP), which functions to further proteolyze remnant signal peptides after they have been cleaved by signal peptidase. Knowledge of the biochemistry and function of individual SPPs are only beginning to be elucidated, and homologues are found in all kingdoms of life. Presenilin and SPP exhibit significant sequence similarity, strongly suggesting they share structural and catalytic features. Thus, a molecular understanding of the more tractable SPP will likely impact drug design for presenilin and y- secretase. The goal of this proposal is to express, characterize, and solve the crystal structure of an extremophilic bacterial SPP ortholog by itself, with a transition-state analog inhibitor and with a substrate mimic. In addition, drug candidates will be screened in silico. This first structure of an intramembrane protease will provide critical insight into the biochemistry of intramembrane proteolysis and enable structure- based AD drug development and screening.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AG027647-03
Application #
7329807
Study Section
Special Emphasis Panel (ZRG1-F04B (20))
Program Officer
Snyder, Stephen D
Project Start
2005-12-01
Project End
2008-01-01
Budget Start
2007-12-01
Budget End
2008-01-01
Support Year
3
Fiscal Year
2008
Total Cost
$3,483
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Yu, Yi; Mena-Barragán, Teresa; Higaki, Katsumi et al. (2014) Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human ?-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants. ACS Chem Biol 9:1460-9
Orwig, Susan D; Tan, Yun Lei; Grimster, Neil P et al. (2011) Binding of 3,4,5,6-tetrahydroxyazepanes to the acid-?-glucosidase active site: implications for pharmacological chaperone design for Gaucher disease. Biochemistry 50:10647-57
Lieberman, Raquel L; D'aquino, J Alejandro; Ringe, Dagmar et al. (2009) Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry 48:4816-27
Landon, Melissa R; Lieberman, Raquel L; Hoang, Quyen Q et al. (2009) Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase. J Comput Aided Mol Des 23:491-500